BLRX - 1.09 Pre-market now at 1.13/1.15 BioLineRx Initiates Phase 1/2 Study of BL-8040 with Atezolizumab to Treat Gastric Cancer; Shares Up 1% Early http://stockcharts.com/c-sc/sc?s=BLRX&p=D&b=5&g=0&i=t98454257153&r=1508330860122 http://stockcharts.com/c-sc/sc?s=BLRX&p=W&b=5&g=0&i=t78493306664&r=1508330840234